Precision Biosciences DTIL
NASDAQ DTIL
$9.15 -0.35 (-3.68%)
At close: Nov 11, 2026 · 4:00 PM EST

Precision Biosciences (DTIL) Liabilities from Discontinued Operations (2022 - 2025)

Updated

Precision Biosciences' Liabilities from Discontinued Operations was $128,000 in fiscal Q4 2023 (quarter ended Dec 31, 2023), down 92.5% from $1.72 million a year earlier.

Analysis

Precision Biosciences (DTIL) Liabilities from Discontinued Operations (2022 - 2025) Analysis & Trends

  • In earlier fiscal years, Liabilities from Discontinued Operations was $1.72 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Precision Biosciences 264.98 Mn -121.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 885,000.00
Jun 30, 2025 885,000.00
Mar 31, 2025 885,000.00
Dec 31, 2024 1.20 Mn
Sep 30, 2024 1.30 Mn
Jun 30, 2024 1.30 Mn
Mar 31, 2024 1.51 Mn
Dec 31, 2023 128,000.00
Sep 30, 2023 1.64 Mn
Dec 31, 2022 1.72 Mn
API Access

Precision Biosciences Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=DTIL&period=max&api_key=YOUR_API_KEY